Growth Metrics

Vivos (RDGL) EBT Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -2.47%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 7.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.70%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 37.81%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.82%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 32.11%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 61.06%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.57%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 14.40%
10 Vivos - - -3,105.00 -15.19%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -15.19%
Sep 30, 2025 -22.34%
Jun 30, 2025 6.41%
Mar 31, 2025 -6.05%
Dec 31, 2024 -79.06%
Sep 30, 2024 -60.08%
Jun 30, 2024 35.32%
Mar 31, 2024 -24.68%
Dec 31, 2023 -52.73%
Sep 30, 2023 -70.13%
Jun 30, 2023 -78.35%
Mar 31, 2023 11.66%
Dec 31, 2022 -11.87%
Sep 30, 2022 25.47%
Jun 30, 2022 -57.83%
Mar 31, 2022 -43.60%
Dec 31, 2021 -26.14%
Sep 30, 2021 80.45%
Jun 30, 2021 32.36%
Mar 31, 2021 31.62%
Dec 31, 2020 51.36%
Sep 30, 2020 58.21%
Jun 30, 2020 52.86%
Mar 31, 2020 4.74%
Dec 31, 2019 -55.21%
Sep 30, 2019 -62.50%
Jun 30, 2019 63.69%
Mar 31, 2019 65.60%
Dec 31, 2018 248.05%
Sep 30, 2018 -119.90%
Jun 30, 2018 -42.85%
Mar 31, 2018 -37.02%
Dec 31, 2017 43.97%
Sep 30, 2017 -28.95%
Jun 30, 2017 -7.11%
Mar 31, 2017 27.27%
Dec 31, 2016 30.70%
Sep 30, 2016 45.33%
Jun 30, 2016 -84.72%
Mar 31, 2016 -112.45%
Dec 31, 2015 29.19%
Sep 30, 2015 -2.31%
Jun 30, 2015 68.45%
Mar 31, 2015 50.81%
Dec 31, 2014 -168.98%
Sep 30, 2014 -13.17%
Jun 30, 2014 -25.09%
Mar 31, 2014 -12.88%
Dec 31, 2013 -7.72%
Sep 30, 2013 6.85%
Jun 30, 2013 -1.03%